Description du projet
Renforcer la collaboration transfrontalière dans la recherche biomédicale
Le financement de la recherche est confronté à des défis importants dans des domaines compétitifs, tels que l’inadéquation entre les stratégies régionales et européennes, la fragmentation des efforts et les contraintes de financement. Il est essentiel de s’attaquer à ces obstacles pour renforcer l’impact et la durabilité des initiatives de recherche dans l’ensemble de l’UE. Le projet TRIAD, financé par l’UE, vise à renforcer la collaboration entre trois laboratoires situés en République tchèque, en Grèce et au Portugal. Précédemment financé par le Fonds européen de développement régional (FEDER), l’objectif était de réduire les disparités économiques entre les régions et de promouvoir la cohésion économique, sociale et territoriale au sein de l’UE. L’objectif principal du projet est de faciliter la collaboration transfrontalière des bénéficiaires du FEDER, le partage de la méthodologie et la participation aux projets Horizon.
Objectif
Over the years, the EU investments, i.e. ERDF and RRF, have played a crucial role in advancing biomedical research in underperforming EU Member States. However, in competitive research fields, ERDF/RRF-funded labs face significant challenges, including mismatches between regional and European approaches, disparities between Horizon thematic priorities and national/regional smart specialization strategies, as well as variations in funding allocation between consortia and single beneficiaries. The absence of coherent internationalization strategies, limited training programs and skilled personnel, fragmented research endeavors, and funding constraints further hinder the development of sustainable research synergies with leading research institutes. To address this pressing need, we propose TRIAD, a program utilizing the upstream synergy model under pathway A to enhance collaboration among three ERDF-funded labs in Greece, Portugal, and the Czech Republic with a scientific focus on the functional role of telomeres in health and disease. Leveraging ERDF funding, the three research teams have developed complementary expertise in research tools, platforms, and approaches at a regional level. The core objective of TRIAD is to enable the individual ERDF beneficiaries to overcome isolation through cross-border collaboration and successful participation in Horizon Europe calls. This will be achieved through a comprehensive collaborative strategy to share methodologies, an extensive human resources development plan, a set of activities to enhance innovation capacity and improve access to European R&I networks, as well as to increase competitiveness in research funding, and establish effective management and administrative structures on site. We anticipate that this strategy will establish a lasting legacy benefiting ERDF beneficiaries and the wider community by fostering a collaborative ecosystem that will extend well beyond the project's duration.
Mots‑clés
Programme(s)
Régime de financement
HORIZON-CSA - HORIZON Coordination and Support ActionsCoordinateur
74100 Rethimno
Grèce